Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ze Yin

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Analysis of Decitabine Therapeutic Effeicacy for Patients with Relapsed MDS/AML and High-Risk AML Patients after HSCT]Qing-Yun Wang, Ze-Yin Liang, Yu-Jun Dong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 8, 2021
[Clinical Efficacy of the MDS Patients Treated by Allo-HSCT]Qing-Yun Wang, Yu-Jun Dong, Qian Wang, et al.
ACS Nano|October 25, 2025
Mitochondria-Targeted Dual-Ion Perturbator Amplifies Cuproptosis for Enhanced Melanoma Immunotherapy and Accelerated Postoperative Wound HealingHan Du, Zhe Li, Shao-Tian Fu, et al.
Biomaterials|May 30, 2017
High purity microfluidic sorting and in situ inactivation of circulating tumor cells based on multifunctional magnetic compositesHongwei Xu, Biao Dong, Shihan Xu, et al.
Fish & Shellfish Immunology|July 2, 2026
SNX8 interacts with THOC7 to negatively regulate IFN 1 response via the TBK1-IRF3 signaling axis in teleost fishMiao-Miao Li, Chu-Xin Wu, Ji-Huan Hu, et al.
World Journal of Hepatology|July 3, 2025
Oncohepatology: Navigating liver injury in the era of modern cancer therapyShuo-Feng Li, Xu Ouyang, Shi Feng, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 1, 2013
[Chemical constituents from cell cultures of Morus alba]Xiao-Yu Tao, De-Wu Zhang, Ri-Dao Chen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2020
[Clinical Analysis for Patients with AML Treated after Allo-HSCT]Qing-Yun Wang, Yu-Jun Dong, Ze-Yin Liang, et al.
Cancer Management and Research|December 12, 2019
Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host DiseaseQing Ya Wang, Yuan Li, Ze Yin Liang, et al.
Phytochemistry|December 14, 2024
Voagafries A-E, undescribed indole alkaloids with anti-glioma activity from Voacanga africanaCai-Feng Ding, Ma-Long Qin, Kun-Ying Zhao, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 7, 2020
[Analysis of Decitabine Therapeutic Effeicacy for Patients with Relapsed MDS/AML and High-Risk AML Patients after HSCT]Qing-Yun Wang, Ze-Yin Liang, Yu-Jun Dong, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|February 8, 2021
[Clinical Efficacy of the MDS Patients Treated by Allo-HSCT]Qing-Yun Wang, Yu-Jun Dong, Qian Wang, et al.
ACS Nano|October 25, 2025
Mitochondria-Targeted Dual-Ion Perturbator Amplifies Cuproptosis for Enhanced Melanoma Immunotherapy and Accelerated Postoperative Wound HealingHan Du, Zhe Li, Shao-Tian Fu, et al.
Biomaterials|May 30, 2017
High purity microfluidic sorting and in situ inactivation of circulating tumor cells based on multifunctional magnetic compositesHongwei Xu, Biao Dong, Shihan Xu, et al.
Fish & Shellfish Immunology|July 2, 2026
SNX8 interacts with THOC7 to negatively regulate IFN 1 response via the TBK1-IRF3 signaling axis in teleost fishMiao-Miao Li, Chu-Xin Wu, Ji-Huan Hu, et al.
World Journal of Hepatology|July 3, 2025
Oncohepatology: Navigating liver injury in the era of modern cancer therapyShuo-Feng Li, Xu Ouyang, Shi Feng, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|May 1, 2013
[Chemical constituents from cell cultures of Morus alba]Xiao-Yu Tao, De-Wu Zhang, Ri-Dao Chen, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 18, 2020
[Clinical Analysis for Patients with AML Treated after Allo-HSCT]Qing-Yun Wang, Yu-Jun Dong, Ze-Yin Liang, et al.
Cancer Management and Research|December 12, 2019
Decitabine-Containing Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Intermediate- and High-Risk Myelodysplastic Syndrome/Acute Myeloid Leukemia: Potential Decrease in the Incidence of Acute Graft versus Host DiseaseQing Ya Wang, Yuan Li, Ze Yin Liang, et al.
Phytochemistry|December 14, 2024
Voagafries A-E, undescribed indole alkaloids with anti-glioma activity from Voacanga africanaCai-Feng Ding, Ma-Long Qin, Kun-Ying Zhao, et al.
Pageof 9